Here are relevant reports on : hedge-fund-administration-market
-
Consumer Identity and Access Management (CIAM) Market by Solutions (Identity Administration, PII Management & Analytics, Access Management, Fraud Detection), Services, Authentication Type, and Vertical - Global Forecast to 2030
The global Consumer IAM market size is projected to grow from USD 14.12 billion in 2025 to USD 22.47 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 9.7 % during the forecast period. IBM (US), Okta (US), SAP (US), Microsoft (US), Ping Identity (US), Thales (France), Broadcom (US), AWS (US), Salesforce (US), OpenText (Canada), Akamai Technology (US), Deloitte (UK), HID Global (US), CyberArk (US), Nevis Security (Switzerland), Simeio Solutions (US), Ubisecure (Finland), OneLogin (US), SecureAuth (US), LoginRadius (Canada), IDology (US), Omada Identity (Denmark), WSO2 (US), WidasConcepts (Germany), FusionAuth (US), Transmit Security (Israel), IDnow (Germany), MiniOrange (US), Strivacity (US) are the key players and other players in the CIAM market.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Global Forecast to 2028
The global veterinary API market, valued at US$8.0 billion in 2022, stood at US$8.5 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2023 to 2028, culminating in a forecasted valuation of US$11.9 billion by the end of the period. The veterinary active pharmaceutical ingredient (API) market is growing due to various factors, including the increased occurrence of transboundary and zoonotic diseases, a rise in the global animal population and pet ownership, and the implementation of improved disease control and prevention measures.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
US Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) - Forecast to 2031
The US injectable drug delivery market, valued at US$285.81 billion in 2025, stood at US$309.90 billion in 2026 and is projected to advance at a resilient CAGR of 8.5% from 2026 to 2031, culminating in a forecasted valuation of US$465.15 billion by the end of the period. The growth of the veterinary contract manufacturing & research market is driven by the increasing adoption of biologics and long-acting injectables, rising demand for patient-centric and self-administration delivery systems, and the need for advanced formulation, device engineering, and scalable manufacturing capabilities.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Immunotherapy Drugs Market by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
The global immunotherapy drugs market, valued at US$255.9 billion in 2023, stood at US$285.3 billion in 2024 and is projected to advance at a resilient CAGR of 15.3% from 2024 to 2029, culminating in a forecasted valuation of US$580.6 billion by the end of the period. This growth is driven by technological advancements in antibody engineering, increasing demand for antibody therapies in clinical cancer treatment, and a growing preference for personalized medicines and targeted therapies.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Identity Governance and Administration Market by Component (Solution and Services), Deployment Type, Organization Size, Industry Vertical (BFSI, Government and Defense, and Telecom and IT), and Region - Global Forecast to 2023
The global identity governance and administration market size is expected to grow from USD 3.8 billion in 2018 to USD 7.7 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 15.2% during the forecast period. Major growth drivers for the market include such as globalization and rise in regulatory compliances. Major vendors offering the identity governance and administration solution across the globe include Oracle (US), IBM (US), SailPoint (US), SAP (Germany), Microsoft (US), CA Technologies (US), Evidian (France), NetIQ (US), One Identity (US), RSA Security (US), Hitachi ID (Canada), Saviynt (US), AlertEnterprise (US), Omada (Denmark), and SecureAuth (US).
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030
The global autoinjectors market, valued at US$1.08 billion in 2023, stood at US$1.40 billion in 2024 and is projected to advance at a resilient CAGR of 13.6% from 2024 to 2030, culminating in a forecasted valuation of US$3.02 billion by the end of the period. Technology advancements in autoinjector devices, such as improved design, the addition of connectivity features for data tracking, Bluetooth connectivity, and dosage reminders, are some of the factors that increase the adoption of autoinjectors and drive market growth.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Europe Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injector, Topical (Cream, Transdermal Patch), Transmucosal, Nasal], Application [Cancer, Diabetes], Care Setting [Hospital, Homecare]- Forecast to 2031
The Europe Pharmaceutical drug delivery market, valued at US$501.6 million in 2025, stood at US$519.6 million in 2026 and is projected to advance at a resilient CAGR of 6.2% from 2026 to 2031, culminating in a forecasted valuation of US$703.2 million by the end of the period. The major trends in this market are self-administration, technology-driven drug delivery, sustainable drug delivery, and drug device combinations.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Warranty Management System Market by Types (Claim & Transaction Management, Warranty Analytics, Billing & Administration Management, Warranty Tracking) by Deployment (On Premise, Cloud), by Verticals, by Regions - Global Forecast to 2020
The warranty management system market size is estimated to grow from USD 1.7 Billion in 2015 to USD 3.4 Billion by 2020, at a CAGR of 14.4% from 2015 to 2020. Warranty management system redefines the contract and warranty management processes by providing integrated software to automate and standardize the warranty allied processes. The report aims at estimating the market size and future growth potential of the warranty management system market across different segments such as software, service, deployment type, vertical, region.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Elastomeric Pumps Market by Product (Continuous Rate, Variable Rate), Treatment (Chemotherapy, Antibiotic, Iron Chelation Therapy), Administration Route (Intravenous, Subcutaneous), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022
The global elastomeric pumps market is expected to reach USD 592.0 Million by 2022 from USD 432.1 Million in 2017, growing at a CAGR of 6.5% from 2017 to 2022. Increasing number of surgeries, wide usage in treatment, rising incidence of chronic diseases, and increasing adoption for disposable infusion pumps, are some of the major driving factors driving the growth of the global elastomeric pumps market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Europe vaccines market, valued at US$10.53 billion in 2024, stood at US$9.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$13.74 billion by the end of the period. The vaccines market is growing due to fast global developments and the commercialization of vaccines, rising rates of infectious diseases, which require preventive measures, and government initiatives to encourage vaccinations, immunization programs, advancements, and investments in new vaccines against various diseases.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
